To determine whether prostaglandin (PG) F 2␣ had a dose-dependent effect upon secretion of progesterone, oligonucleosome formation, or loss of luteal weight, ewes on Day 9 or 10 of the estrous cycle were administered 0, 3, 10, or 30 mg PGF 2␣ per 60 kg BW (i.v.), and luteal tissue was collected 9 and 24 h after injection. All doses of PGF 2␣ decreased (P Ͻ 0.05) concentrations of progesterone in sera by 9 h; however, in ewes treated with 3 mg PGF 2␣ , concentrations of progesterone were similar to control values at 24 h and higher (P Ͻ 0.05) than those in the 10-or 30-mg groups. Concentrations of progesterone in sera over all dose levels were highly correlated to luteal concentrations of mRNA encoding steroidogenic acute regulatory protein (P Ͻ 0.001), cytochrome P450 side-chain cleavage (P Ͻ 0.02), and 3␤-hydroxysteroid dehydrogenase (P Ͻ 0.01). Corpora lutea collected at 24 h from ewes treated with the 10-and 30-mg doses of PGF 2␣ weighed less (P Ͻ 0.05) than those from controls. Oligonucleosomes were not present in luteal tissues from control ewes. Surprisingly, all doses of PGF 2␣ -induced oligonucleosomes in a majority of animals at 9 h and in a majority of ewes treated with 10 and 30 mg of PGF 2␣ at 24 h. In conclusion, 3 mg of PGF 2␣ per 60 kg BW transiently decreased serum concentrations of progesterone and induced oligonucleosome formation, but did not result in reduced luteal weight. The 10-and 30-mg doses of PGF 2␣ decreased secretion of progesterone and induced oligonucleosome formation and luteolysis.
INTRODUCTION
Luteal regression in the ewe is characterized by a rapid decline in concentrations of progesterone in serum followed by decreased luteal weight [1] . It is known that binding of prostaglandin (PG) F 2␣ to its receptor decreases luteal synthesis of progesterone and causes luteal cell death [2] . The protein kinase C (PKC) and calcium second messenger pathways appear to mediate the actions of PGF 2␣ [2] . Pharmacological activation of PKC mimics the antisteroidogenic effects of PGF 2␣ [3, 4] but does not cause luteal cell death [4] , which is thought to be caused by an influx of calcium [5] . Thus, decreased secretion of progesterone appears to be regulated by a different second messenger system than luteal cell death, although both processes are induced by PGF 2␣ .
Administration of a luteolytic dose of PGF 2␣ decreases mRNA encoding several proteins important for regulation of progesterone synthesis including the receptors (R) for LH [6, 7] , low-density lipoprotein [8] , and PGF 2␣ [9] [10] [11] as well as steroidogenic acute regulatory (StAR) protein [12, 13] , cytochrome P450 side-chain cleavage enzyme (P450 scc ) [14] , and 3␤-hydroxysteroid dehydrogenase/⌬ 5 ,⌬ 4 isomerase (3␤-HSD) [4, 14, 15] . However, whether decreased concentrations of specific mRNAs, and presumably the specific protein, is the key to decreased concentrations of progesterone in sera following treatment with PGF 2␣ is not clear. Quantities of cytochrome P450 scc and 3␤-HSD proteins do not decrease until after secretion of progesterone has already declined [16] . Injection of PGF 2␣ also induces oligonucleosome formation in luteal tissue, a biochemical indicator of apoptosis [4, [17] [18] [19] . Once a cell forms oligonucleosomes it is irreversibly committed to undergo cell death [20] . Induction of oligonucleosome formation occurs after concentrations of progesterone in serum and luteal tissue have decreased, but before observed decreases in luteal weight [14, 19] . Thus, formation of oligonucleosomes has been associated with loss of luteal tissue.
In the ewe and cow, PGF 2␣ is released from the uterus in a pulsatile manner towards the end of the estrous cycle to induce luteolysis. Pulses of PGF 2␣ increase in both frequency and amplitude during the period of luteal regression [21] [22] [23] . However, the largest peaks of PGF 2␣ occur after concentrations of progesterone in sera have already dramatically decreased. Thus, the physiological role of these large pulses of PGF 2␣ in luteal regression is unclear. Therefore, the hypothesis to be tested was that a single, low dose of PGF 2␣ would decrease secretion of progesterone without causing luteolysis, whereas a single, high dose of PGF 2␣ would result in both decreased secretion of progesterone and luteolysis.
MATERIALS AND METHODS
Western range ewes were used in all experiments and observed for estrus (Day 0) with the aid of vasectomized rams. Ewes were weighed 1 day before the start of the experimental protocol, and PGF 2␣ was administered on a per kilogram of body weight basis. The average body weight of the ewes used for experiment 1 was 60 kg. All experimental protocols were approved by the Colorado State University Animal Care and Use Committee.
Experimental Design Experiment 1. Ewes on Day 9 or 10 of the estrous cycle were administered a single intrajugular injection of 0, 1, 3, 10, or 30 mg PGF 2␣ (Lutalyse; Upjohn Company, Kalamazoo, MI) per 60 kg BW (n ϭ 4 ewes per dose). Doses of PGF 2␣ were administered in 1 ml saline with ewes in the 0 dose group receiving only saline. Dilutions of PGF 2␣ were made within 2 h of injection. The i.v. route of injection was used to ensure that corpora lutea in ewes within a treatment group would be exposed to similar doses and to prevent variation due to site of injection and absorption rates seen with i.m. injection. Ewes were bled Ϫ1, 0, 2, 4, 6, 9, 12, 24, 36, and 48 h relative to the time of injection of PGF 2␣ , and concentrations of progesterone in sera were determined by RIA [24] . Experiment 2. Ewes on Day 9 or 10 of the estrous cycle received injections of 0, 3, 10, or 30 mg PGF 2␣ per 60 kg BW into the jugular vein as described for experiment 1. Corpora lutea were collected 9 or 24 h after injection of PGF 2␣ (n ϭ 5 ewes per time per dose). These times were based on the results of experiment 1, in which progesterone levels reached their nadir at 9 h, and by 24 h were back to pre-injection levels in ewes receiving the 3-mg dose of PGF 2␣ . After collection, corpora lutea were decapsulated, weighed, frozen in liquid nitrogen, and stored at Ϫ70ЊC until isolation of poly A ϩ RNA and DNA. Blood samples were collected by jugular venipuncture at the time of tissue collection for determination of serum concentrations of progesterone.
Determination of Concentrations of Progesterone in Sera
Concentrations of progesterone in sera from experiments 1 and 2 were determined in 4 RIAs [24] . Intraassay coefficients of variation (CV) averaged 8%, and the interassay CV was 12.4%. The limit of sensitivity of all assays was less then 56 pg/ml.
Quantification of mRNAs Encoding LHR, PGF 2␣ -R, StAR, P450 scc , and 3␤-HSD Unless otherwise specified, all materials were purchased from Sigma Chemical Company (St. Louis, MO) or Fisher Scientific (Denver, CO). Polyadenylated RNA (Poly A ϩ RNA) was isolated using oligodeoxythymidine (dT) cellulose as previously described [6, 25] . Tissue samples from one ewe treated with the 3-mg and 10-mg doses of PGF 2␣ collected at 9 h were lost during isolation and therefore not included in RNA analysis. Concentrations of mRNA in isolated samples were determined by absorbance at 260 nm.
Concentrations of mRNAs encoding LHR [6] , PGF 2␣ -R [9] , StAR [12] , P450 scc [26] , and 3␤-HSD [27] were determined by slot blot analysis as previously described. Radioactive cDNAs were generated with the random primer method [28] and had specific activities ranging from 0.4 to 0.5 ϫ 10 9 dpm/g DNA. Standard curves were linear, with correlations (r 2 ) between amount of standard added and the resulting densitometric readings ranging from 0.95 to 0.99. Intraassay CVs were 10%, 11%, 12%, 14%, and 16% for mRNAs encoding LHR, PGF 2␣ -R, StAR, P450 scc , and 3␤-HSD, respectively. Sensitivity of the assay, as determined by the lowest detectible point on the standard curve, was 1.79, 0.53, 1.98, 0.46, and 1.7 fmol/g poly A ϩ RNA for mRNAs encoding LHR, PGF 2␣ -R, StAR, P450 scc , and 3␤-HSD, respectively. Presence of oligonucleosomes in luteal samples was determined by ethidium bromide staining of DNA following gel electrophoresis [17] .
Statistical Analysis
All statistical analyses were performed with the general linear model procedure of SAS [29] . To determine whether the number of ewes in the PG 2␣ treatment groups that contained oligonucleosomes in their corpora lutea was different from the number in the saline-treated group, chi-square analysis was performed. To account for variability in baseline concentrations of progesterone in sera among ewes, all values post-injection were expressed as a percentage of the average value of the Ϫ1-h and 0-h samples. Because of non-normal distribution (Wilk-Shapiro test) and heterogeneous variance (F max test), respectively, data regarding concentrations of progesterone in sera 9 h after injection in experiment 1 and data regarding concentrations of mRNA encoding PGF 2␣ -R were transformed before final statistical analysis. However, the means Ϯ SEM of raw data are presented. Differences between least-squares means were determined by least-significant differences. Significance of correlation coefficients between parameters was determined with Pearson's test.
RESULTS

Experiment 1
Injection of all doses of PGF 2␣ decreased (P Ͻ 0.05) concentrations of progesterone in sera within 4 h when compared to values obtained from saline-treated control ewes (Fig. 1) . Concentrations of progesterone in sera returned to values that were not different from those in controls in ewes receiving injections of 1, 3, or 10 mg PGF 2␣ / 60 kg BW by 12, 18, and 24 h after injection, respectively (Fig. 1) . However, ewes treated with 30 mg of PGF 2␣ /60 kg BW had less (P Ͻ 0.05) progesterone in sera than did controls at all times sampled after 4 h post-injection (Fig. 1) .
Experiment 2
There were no significant differences in any parameter measured between the control groups at 9 and 24 h. Concentrations of progesterone in sera were lower (P Ͻ 0.05) in ewes treated with any dose of PGF 2␣ at 9 and 24 h after injection than values obtained from controls (Table 1) . However, concentrations of progesterone in sera in ewes treated with 3 mg PGF 2␣ per 60 kg BW were greater (P Ͻ 0.05) than values obtained from ewes that had received 10 or 30 mg PGF 2␣ . Corpora lutea collected from ewes treated with 10 or 30 mg, but not 3 mg, PGF 2␣ /60 kg BW 24 h before collection weighed less (P Ͻ 0.05) than those collected from saline-treated ewes (Table 1) . Luteal tissue collected 9 h after treatment contained oligonucleosomes in 4 of 5, 3 of 5, and 5 of 5 ewes treated with 3, 10, or 30 mg PGF 2␣ , respectively ( Fig. 2; Table 1 ). None of the ewes that received saline showed evidence of oligonucleosome formation. By 24 h after injection of PGF 2␣ , luteal tissue collected from 4 of 5 or 5 of 5 ewes that had received 10 or 30 mg PGF 2␣ /60 kg BW contained oligonucleosomes. However, there were no oligonucleosomes present in luteal tissue collected from 4 of 5 ewes that received 3 mg PGF 2␣ / 60 kg BW or in any ewes treated with saline (Table 1) .
Luteal concentrations of mRNA encoding StAR were decreased by all doses of PGF 2␣ 9 h after injection (Table  2) . However, by 24 h after injection, ewes receiving the 3-mg dose of PGF 2␣ had concentrations of StAR mRNA that were not different from those obtained from saline-treated ewes ( Table 2 ). Concentrations of StAR mRNA and progesterone in sera were highly correlated (R ϭ 0.74, P Ͻ 0.001). Concentrations of mRNA encoding P450 scc (Table  2) were decreased within 9 h in ewes administered 30 mg PGF 2␣ and at 24 h in ewes administered 10 mg or 30 mg PGF 2␣ /60 kg BW. This parameter was also correlated with concentrations of progesterone in sera (R ϭ 0.40, P Ͻ 0.02). The 3-mg dose of PGF 2␣ did not decrease luteal concentrations of mRNA encoding 3␤-HSD at 9 or 24 h following injection (Table 2 ). However, 10 mg or 30 mg of PGF 2␣ decreased 3␤-HSD mRNA at 9 h, and 30 mg PGF 2␣ also suppressed concentrations of mRNA encoding 3␤-HSD 24 h after injection. Concentrations of mRNA encoding 3␤-HSD were also correlated with concentrations of progesterone in sera (R ϭ 0.46, P Ͻ 0.01). While 3 mg of PGF 2␣ /60 kg BW did not affect concentrations of mRNA encoding LHR, higher doses of PGF 2␣ decreased LHR mRNA at both 9 and 24 h after injection (Table 2) . Concentrations of mRNA encoding the PGF 2␣ -R were decreased by all doses of PGF 2␣ 9 h following injection. However, only the highest dose of PGF 2␣ suppressed concentrations of mRNA encoding PGF 2␣ -R 24 h after injection.
DISCUSSION
The low dose (3 mg/60 kg BW) of PGF 2␣ decreased secretion of progesterone without causing luteolysis, whereas high doses of PGF 2␣ (10 and 30 mg/60 kg BW) caused both decreased secretion of progesterone and luteolysis. One very interesting observation was that PGF 2␣ -induced oligonucleosome formation in corpora lutea collected from most ewes by 9 h after injection, including 4 of 5 ewes that received 3 mg/60 kg BW PGF 2␣ . However, at 24 h, only 1 of 5 ewes that had received the 3-mg dose of PGF 2␣ had oligonucleosomes in luteal tissue. Thus, it would appear that corpora lutea from these ewes had recovered from the PGF 2␣ injection and that induction of oligonucleosomes in luteal tissue was not a good indicator of impending luteolysis.
In morphological studies of the ovine corpus luteum, most of the cells observed with apoptotic characteristics were capillary endothelial cells, and no more than 5% of parenchymal cells showed signs of apoptosis at any one time following PGF 2␣ -induced luteolysis [30] . Thus, it is likely that a majority of the cells that were undergoing apo-ptosis in the current study were endothelial cells. However, there are conflicting data regarding the identification of cells undergoing apoptosis during luteolysis [17] [18] [19] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . It has been estimated that if as few as 3% of the cells contain oligonucleosomes, 25% of the tissue will be destroyed within 24 h [40] .
Treatment with PGF 2␣ reduced concentrations of all mRNAs examined when given at the 30 mg/kg BW dose. This result was similar to results previously obtained for these mRNAs [4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] 27] . However, even a nonluteolytic dose of PGF 2␣ (3 mg/kg BW) induced severe reductions in mRNA encoding StAR and PGF 2␣ -R at 9 h post-treatment, although concentrations of these mRNAs returned to values similar to those in controls within 24 h. In contrast, concentrations of mRNA encoding P450 scc and LHR appeared to be less sensitive to PGF 2␣ , and higher doses of PGF 2␣ were necessary to cause suppression, although concentrations of progesterone in sera were reduced by all doses of PGF 2␣ . Thus, reduced levels of mRNA encoding LHR and P450 scc and their associated protein are probably not involved in the PGF 2␣ -induced decrease in progesterone secretion. In addition, we and others have shown that the reduction in concentrations of mRNA encoding 3␤-HSD following PGF 2␣ injection did not lead to reduced 3␤-HSD protein or its enzyme activity [14, 27] until well after secretion of progesterone had decreased. In contrast, mRNA encoding StAR and mitochondrial StAR protein levels are highly correlated in bovine corpora lutea [13] , and StAR has an effective half-life of 3-5 min [41, 42] . Thus, reduced concentrations of StAR mRNA would be expected to rapidly lead to reduced StAR protein. Since StAR is essential to gonadal steroid synthesis [43] , reduced StAR protein would lead to reduced progesterone synthesis. Indeed, we observed a very strong correlation between mRNA encoding StAR and concentration of progesterone in serum.
In conclusion, we propose that low concentrations of PGF 2␣ decrease synthesis of progesterone in luteal tissue, at least in part through down-regulation of mRNA encoding StAR. Larger doses of PGF 2␣ are then released from the uterus and cause luteolysis. Luteolysis involves the induction of apoptosis, probably in capillary endothelial cells, which then leads to collapse of the vascular system and death of additional luteal cells. The corpus luteum can recover from a low concentrations of PGF 2␣ even though oligonucleosomes may be detected 9 h after treatment. It is possible that the reduced synthesis of progesterone in luteal tissue is a necessary prerequisite for apoptotic cell death; however, it would not appear to be the initiating factor as mimicking the antisteroidogenic effects of PGF 2␣ by administration of agents that activate the PKC pathway does not induce oligonucleosome formation or luteolysis [4] . Finally, since the corpus luteum can recover from low doses of PGF 2␣ and secrete normal amount of progesterone, we hypothesize that the high concentrations of PGF 2␣ observed late in the period of luteal regression [21] [22] [23] ensure destruction of the luteal tissue to prevent inappropriate progesterone synthesis by the corpus luteum during the periovulatory period.
